Gilde Health­care bags $657M to fu­el 'holis­tic' search for af­ford­able drugs, tech­nolo­gies

Gilde Health­care, a Dutch in­vest­ment firm out to back health­care com­pa­nies that can bring new prod­ucts to the mar­ket at af­ford­able prices, has an­oth­er €600 mil­lion (close to $657 mil­lion) to bet on a new slate of com­pa­nies.

As with its pre­vi­ous funds, Gilde will con­tin­ue to look across Eu­rope and North Amer­i­ca for com­pa­nies work­ing on dig­i­tal health­care, med­ical tech­nol­o­gy and ther­a­peu­tics — a “holis­tic ap­proach” that can lead to the “most op­ti­mal and cost-ef­fec­tive so­lu­tion for the in­di­vid­ual pa­tient,” ac­cord­ing to man­ag­ing part­ner Pieter van der Meer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER